Tom Arne Thorsen
Director/Board Member at Hubro Therapeutics AS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon Amund Eriksen | M | - |
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | 6 years |
| Aitana Peire | M | - |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | - |
| Øyvind Kongstun Arnesen | M | 67 |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | - |
| Kjeld-Håkon Nilsen | M | - |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jónas Einarsson | M | 67 |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tom Arne Thorsen
- Personal Network
